Definition of Dementia n An acquired complex of intellectual deterioration which affects at least two areas of cognitive function. n A syndrome, not a.

Slides:



Advertisements
Similar presentations
APOE Genotype Effects on Alzheimer’s Disease Clinical Onset, Epidemiology, and Gompertzian Aging Functions J.Wesson Ashford, M.D., Ph.D. Stanford / VA.
Advertisements

Management of Early Dementia Dr Eleanor Mullan Consultant Psychiatrist Mental Health Services for Older People South Lee, Cork Feb 2011.
Martha Stearn, MD Institute for Cognitive Health St John’s Medical Center Jackson, Wyoming.
Alzheimer’s Disease By Juan Escobar Per: 4. Alzheimer’s Disease  A common form of dementia of unknown cause, usually beginning in late middle age, characterized.
Developmental Health Psychology. Aging Primary Aging Primary Aging –“normal” senescence Secondary Aging Secondary Aging –“pathological” senescence.
Dementia & Delirium in Surgical Patients Damian Harding Department of Geriatric Medicine February 2008.
Dementia Drugs: Mainstream and Alternative Medicines Susan Kurrle.
Introduction to neuropsychiatric disorders
DEMENTIA JOE BEDFORD IBRAHIM ELSAFY ESCALIN PEIRIS.
Cognitive Disorders Madiha Anas Institute of Psychology Beaconhouse National University.
 Dementia By: Vicky Zakrzewski M/F 9:25 Human Exceptionalities.
Alzheimer's Disease Guadalupe Lupian Mrs. Marsh 1 st period.
Recognition of Dementia Syed Zaman Consultant Physician Geriatric Medicine Palmerston North Hospital.
The Brain. Problems with the Brain… Dementia – group of symptoms affecting intellectual and social abilities severely enough to interfere with daily.
Alzheimer’s Assessment Assessing the Cognitive-Linguistic effects of Alzheimer’s.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 22 Alzheimer’s Disease.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Alzheimer’s Disease Angela Singh, PharmD Associate Professor of Pharmacy Practice Florida A&M University College of Pharmacy & Pharmaceutical Sciences.
Burcu Ormeci, MD Department of Neurology.  In the United States;  As many as 7 million people have dementia  Almost half of all people age 85 and older.
ALZHEIMER’S PART 2. AD VIDEO
Alzheimer's Disease and the Family What Is Alzheimer’s Disease? Prepared by: Dr. Jan Park Gerontology Specialist Oklahoma Cooperative Extension Service.
Biological Myths of Aging Memory declines drastically with age for all people. IQ declines drastically with age in all people. Learning becomes more difficult.
Cognitive Impairment Disorders. Assessing Brain Damage  Mental status examination  Information about current behavior and thought including orientation.
Clear organic causes, where primary symptom is a significant deficit in cognitive ability changes in the person’s personality and behavior (due to the.
Alzheimer’s Disease Landscape
DEMENTIA AND ALZHEIMER'S DISEASE. IMPAIRMENT OF BRAIN FUNCTION ( DECLINE IN INTELLECTUAL FUNCTIONING) THAT INTERFERES WITH ROUTINE DAILY ACTIVITIES. MENTAL.
By: Tasso Skountzouris David Schiano. General Description  Alzheimer’s is one the most common form of Dementia  Dementia causes a loss of brain function.
Alzheimer’s Disease Causes, Effects, and Treatments.
Introduction to neuropsychiatric disorders
Cristopher Ramirez Psychology Period 6. A common form of dementia, usually beginning in late middle age, characterize by memory lapses, confusion, emotional.
Copyright © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 33 Delirium and Dementia.
NOW WHERE HAVE I PUT MY GLASSES? A DISCUSSION AROUND DEMENTIA Dr Marion Overton U3A SCIENCE 19TH JUNE 2015.
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
 Alzheimer's disease (AD), also known as Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer’s is the most common form of dementia. This.
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
COLUMBIA PRESBYTARIAN HOSPITAL CENTER
10 signs to early detection 1. Memory loss that affects daily life 2. Challenges in planning or solving problems 3. Difficulty completing projects at.
CONFUSION & DEMENTIA CHAPTER 35.
ALZHEIMER’S DISEASE Sania Munir Medical Biotechnology (BIOT 412)
Dementia. What is Dementia? Dementia is a gradual decline of mental ability that affects your intellectual and social skills to the point where daily.
Cognitive Disorders Chapter 15. Defined as when a human being can no longer understand facts or connect the appropriate feelings to events, they have.
A Lifetime of Quality Care That’s Convenient & Complete Alzheimer’s Disease Robert Grimshaw, MD FACP A Lifetime of Quality Care That’s Convenient & Complete.
The Dementias Dr Giles Richards Consultant Psychiatrist CFT.
Assessment and Diagnosis of Dementia Dr Alison Haddow.
Epidemiology of Alzheimer’s Disease
Module 2: Alzheimer’s & Other Dementias – The Basics A Public Health Approach to Alzheimer’s and Other Dementias.
Mosby items and derived items © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 44 Confusion and Dementia.
DEMENTIA ABDULMAJEED ALOLAYAH What is DEMENTIA ? It is a chronic global impairment of cognitive functions without disturbed consciousness.
Dementia: Alzheimer’s Disease Cyril Evbuomwan Patient Group Meeting 1 st December 2015.
Amyotrophic lateral sclerosis
Alzheimer's disease M O Jamali, H Saeed & T Mathew.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
Dementia Nicholas Cascone, PA-C.
Neurobiology of Dementia Majid Barekatain, M.D., Associate Professor of Psychiatry Neuropsychiatrist Isfahan University of Medical Sciences Ordibehesht.
Alzheimer’s disease.
Alzheimer's By Emily Toro Period 1.
Used to be called Dementia Neurocognitive Disorders.
Orientation to Early Memory Loss. Let’s look for some answers… What is happening? What should I do? Where should I go?
Neurocognitive Disorders & Geropsych Neurocognitive Disorders & Geropsych Chapters 22 & 34.
Alzheimer’s Disease (AD)
Master’s Advanced Curriculum (MAC) Teaching Module: Advanced Practice in Mental Health Settings Acknowledgement: The development of this PowerPoint was.
Chapter 14 Neurocognitive Disorders
Alzheimer Disease: An Overview. What is Dementia? Dementia is a set of symptoms, which includes loss of memory, understanding, and judgment.
The Malfunctioning Mind: Degenerative Diseases of the Brain
Master’s Advanced Curriculum (MAC) Teaching Module: Advanced Practice in Mental Health Settings Acknowledgement: The development of this PowerPoint was.
Cognitive Disorders and Aging
What is Dementia? A term that describes a wide range of symptoms associated with a decline in memory or other thinking skills. Dementia may be severe.
Chapter 30 Delirium and Dementia
Chapter 93 Dementias and Related Disorders
Chapter 25 The Elderly.
Presentation transcript:

Definition of Dementia n An acquired complex of intellectual deterioration which affects at least two areas of cognitive function. n A syndrome, not a diagnosis. n In the past, commonly referred to as senility or “hardening of the arteries”

Cognitive Functions n Memory n Orientation n Language n Judgement n Perception n Attention n Ability to perform tasks in sequence

Dementia = Brain failure n Two basic types 1) Reversible dementias 2) Irreversible dementias n All dementias are treatable to a degree

Reversible Dementias n Intoxications n Infections n Metabolic disorders n Major depression n Brain tumors n Head injuries n Normal pressure hydrocephalus

Irreversible Dementias n Alzheimer’s disease n Multi-infarct or vascular dementia n Parkinson’s disease n Lewy Body disease n Creutzfeldt-Jakob disease n Pick’s disease n Huntington’s disease n AIDS dementia complex n Progressive aphasia

Diagnostic Evaluation of Dementia n History from patient and relative or friend n Clinical exam n Blood work: CBC, Chem profile, Thyroid function tests, Syphilis serology, Vit B12, Folate n Brain scan, CT or MRI n If indicated: - Psychological testing - HIV - Brain biopsy - SPECT or PET scan - Lumbar puncture - EEG

Criteria for Probable Alzheimer’s Disease n Dementia established by clinical and neuropsychological examination n Deficits in at least two areas of cognition n Progressive worsening of memory and other cognitive functions n No disturbances of consciousness n Onset between ages 40 and 90 n Absence of other disorders to account for dementia

Prevalence of Alzheimer’s Disease n More than 4 million Americans plus their families n Number doubles every 5 years after age 65 n Estimated cost of $100 billion annually n Numbers may triple by 2050

Prevalence of Alzheimer’s Disease by Age SOURCE: Evans, D.A. et al. (1989). Journal of the American Medical Association. Vol. 262:

Stages of Alzheimer’s disease FunctionEarly Stage MemoryRoutine loss of recent memory LanguageMild aphasia (word finding difficulty) OrientationSeeks familiar and avoids unfamiliar MotorSome difficulty writing and using objects Mood and behaviorApathy & depression Activities of Needs reminders with some ADL’s daily living (ADL)

FunctionMiddle Stage MemoryChronic, recent memory loss LanguageModerate aphasia OrientationMay get lost at times, even inside the home MotorRepetitive actions, apraxia Mood and behaviorPossible mood and behavioral disturbances Activities of Needs reminders and help with daily living (ADL) most ADL’s Stages of Alzheimer’s disease

FunctionLate Stage MemoryMixes up past and present LanguageExpressive and receptive aphasia OrientationMisidentifies familiar persons and places MotorBradykinesia, at risk for falls Mood and behaviorGreater incidence of mood and behavioral disturbances Activities of Needs reminders with all ADL’s daily living (ADL) Stages of Alzheimer’s disease

FunctionTerminal Stage MemoryNo apparent link to past or present LanguageMute or few incoherent words OrientationOblivious to surroundings MotorLittle spontaneous movement, dysphagia, myoclonus, seizures Mood and behaviorCompletely passive Activities of Requires total care daily living (ADL) Stages of Alzheimer’s disease

Alzheimer’s Disease & Brain Changes n Loss of brain cells and mass n Neurofibrillary tangles n Neuritic plaques n Change in blood flow & glucose utilization

Neurotransmitters n Facilitate communication among nerve cells n Acetylcholine production & other neurotransmitters reduced in Alzheimer’s disease n Communication between nerve cells disrupted n Nerve cells die

Definite Risk Factors for Alzheimer’s Disease n Increasing age n Family history; genetics n Female gender n Down Syndrome

Genes Linked to Alzheimer’s Disease Chromosome Type Age of Onset % of Cases Gene 21 Autosomal < 1% APP (Amyloid Dominant precursor protein) 14 Autosomal < 1% Presenilin 1 Dominant 1 Autosomal < 1% Presenilin 2 Dominant 19 Risk Factor > 60 > 50% ApoE 4 12 Risk factor > 70? A2M Source: Marx, J., (1998, July 24) Science, Vol. 281, 509.

Possible Risk Factors for AD n Environmental toxins n Low formal education & occupational attainment n Previous head trauma n Cerebrovascular disease

Strategies for Medical Treatment of Alzheimer’s Disease n Prevention of disease n Delay onset n Slow rate of progression n Treat primary symptoms (cognitive) n Treat secondary symptoms (behavioral)

Tacrine (COGNEXTM) n Approved for treatment of AD in 1993 n Intended for use with mildly & moderately impaired patients n Limited benefit for a limited duration in a minority of patients n High risk of adverse effects n Rarely prescribed today

Donepezil (ARICEPTTM) n Approved for treatment of AD in 1996 n Intended for use with mildly & moderately impaired patients n Improvement or stability in almost half of patients during clinical trials; long-term effects unknown n Minimal adverse effects, usually at higher dose n Dosage 5 mg or 10 mg tablet once at night

Rivastigmine (EXELONTM) n Approved in 2000 for treatment of mild to moderate AD n Improvement or stability in a majority of patients during clinical trials who had highest dose n Benefits and minimal adverse effects tied to increasing dosage

Galantamine (REMINYL TM ) n Approved in 2001 for treatment of mild to moderate AD n Twice daily dosage starting at 4 mg tablets each, increasing to 8 mg at 4 weeks, then to a maximum of 12 mg after 4 more weeks n Increasing dosage tied to greater benefit and more side effects

Potential Treatments/ Prevention n Non-steroidal anti-inflammatory drugs (NSAIDs) n Antioxident agents n Estrogen n Alternative medicine n Others???

Directions for Research n Further identify risk factors & underlying biological causes n Improve diagnostic tools n Develop better drugs n Improve approaches to care n Reduce caregiver distress

Care of Persons with Alzheimer’s disease n Create a supportive atmosphere n Structure appropriate activities & routine n Design “dementia friendly” environments n Facilitate peer groups (for emotional support & shared activities)

Help for Family Caregivers n Offer education, training and consultation n Promote respite services, e.g., adult day care, companion n Offer individual and family counseling n Encourage participation in support groups